Insider Buying: OptiBiotix Health (LON:OPTI) Insider Buys 95,238 Shares of Stock

OptiBiotix Health Plc (LON:OPTI) insider Stephen O’Hara bought 95,238 shares of the firm’s stock in a transaction dated Tuesday, September 23rd. The stock was acquired at an average cost of GBX 11 per share, with a total value of £10,476.18.

Stephen O’Hara also recently made the following trade(s):

• On Monday, September 22nd, Stephen O’Hara bought 50,000 shares of OptiBiotix Health stock. The stock was acquired at an average cost of GBX 10 per share, with a total value of £5,000.

OptiBiotix Health Stock Up 3.7%

Shares of OptiBiotix Health stock opened at GBX 10.63 on Friday. The stock has a market cap of £10.98 million, a PE ratio of -577.45 and a beta of 1.71. The business has a fifty day simple moving average of GBX 10.97 and a 200-day simple moving average of GBX 13.81. OptiBiotix Health Plc has a 12 month low of GBX 9 and a 12 month high of GBX 23.50.

OptiBiotix Health (LON:OPTI) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative return on equity of 36.76% and a negative net margin of 524.43%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.